$2.96
▼ $0.51 (-14.7%)
NAGE
Niagen Bioscience Inc. Common Stock
Health Care
Investor Score
53C-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
16
Technical
73
Fundamental
74
Growth
55
Fair Value
68
News
58
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.